Results 31 to 40 of about 18,650 (251)

Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas. [PDF]

open access: yes, 2017
Primary cutaneous CD8-positive aggressive epidermotropic T-cell lymphoma is a rare and poorly characterized variant of cutaneous lymphoma still considered a provisional entity in the latest 2016 World Health Organization Classification of Cutaneous ...
Duvic, Madeleine   +19 more
core   +1 more source

Learning differential diagnosis of erythemato-squamous diseases using voting feature intervals [PDF]

open access: yes, 1998
Cataloged from PDF version of article.A new classification algorithm, called VFI5 (for Voting Feature Intervals), is developed and applied to problem of differential diagnosis of erythemato-squamous diseases.
Demiroz, G., Guvenir, H. A., Ilter, N.
core   +1 more source

Pityriasis Rosea: A rash that should be recognized by the primary care physician. Study of 30 cases

open access: yesActa Pediátrica de México, 2014
Background: Pityriasis rosea is an acute disseminated rash of unknown etiology and prolonged duration, characterized by erythematous- squamous plaques.
Igor López-Carrera   +1 more
doaj   +1 more source

Analysis of CARD14 Polymorphisms in Pityriasis Rubra Pilaris: Activation of NF-κB. [PDF]

open access: yes, 2015
Pityriasis rubra pilaris (PRP) is a rare inflammatory papulo-squamous disorder manifesting with palmoplantar keratoderma and follicular hyperkeratotic papules which tend to coalesce into large, scaly, erythematous plaques often progressing to exfoliative
Andrews, Jonathan   +9 more
core   +2 more sources

Pityriasis Rosea Recurrence is Much Higher than Previously Known: A Prospective Study

open access: yesActa Dermato-Venereologica, 2019
Pityriasis rosea is a common acute exanthema of unknown aetiology, which causes severe anxiety. In this study, the demographic data of pityriasis rosea patients, who presented to our clinic between 2013 and 2017, were prospectively recorded. The patients
Mavişe Yüksel
doaj   +1 more source

Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris. [PDF]

open access: yes, 2017
Treatment of pityriasis rubra pilaris (PRP) is solely based on its resemblance to psoriasis rather than any knowledge of its pathomechanism. Insight into pathogenic mediators of inflammation is essential for targeted and valid treatment options that ...
Conrad, C.   +8 more
core   +2 more sources

Molecular Characterization of Malassezia furfur isolated from patients with pityriasis versicolor compared to healthy control in Baghdad, Iraq

open access: yesمجلة كلية الطب, 2018
Background: Humans skin, is the largest organ of the integumentary system, it has multiple layers of ectodermal tissue and guards the underlying muscles, bones, ligaments and internal organs.
Abbas M. Al-Ammari   +2 more
doaj   +1 more source

The Prevalence of Dermatological Infection in Outpatient Dermatology Clinic of RSUD Wonosari in January-September 2016 [PDF]

open access: yes, 2017
Background: The Skin is a complex organ that protects humans from their surrounding environment, like an infectious pathogenic agent, sunlight exposure, temperature, or other exposures.
Nabila, L. M. (Lamya)   +2 more
core   +2 more sources

A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Background: Pityriasis rosea is an acute self-limiting skin disorder of unknown aetiology. Recently human herpes virus 6 and 7 has been hypothesized to be the cause of pityriasis rosea. Objective: To determine the efficacy of acyclovir, an anti-viral
Satyaki Ganguly
doaj   +1 more source

Drug-related pityriasis rubra pilaris with acantholysis [PDF]

open access: yes, 2013
Introduction. Acantholysis is rarely reported histological feature of Pityriasis rubra pilaris (PRP), recently recognized as having diagnostic specificity for differentiating PRP from psoriasis. Case report.
Duran Verica D.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy